Comparative analysis of lipid profiles among patients with type 2 diabetes mellitus, hypertension and concurrent type 2 diabetes, and hypertension: A view of metabolic syndrome

Journal of the National Medical Association

Volumn 95, Issue 5, 2003, Pages 328-334

  Isezuo, S A ^a   Badung, S L H ^b   Omotoso, A B O ^b  

^a USMANU DANFODIYO UNIVERSITY   (Nigeria)

^b NONE

Author keywords

Diabetes mellitus; Dyslipidaemia; Hypertension; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; METABOLIC SYNDROME X;

DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; LIPIDS; METABOLIC SYNDROME X; RISK FACTORS;

EID: 0042320551     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1989; 37: 1595-1607.
2. Wannamethee SG, Sheper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Human Hypertens, 1998; 12: 735-741.
3. Akinkugbe OO. Non-communicable diseases in Nigeria: the next epidemic. Nigerian Journal of Medical Practice. 2000; 3: 904-907.
4. Bakori AG, Onyemelukwe GC, Sani BG, Hassan SS, Aliyu TM. The prevalence of diabetes in suburban northern Nigeria: results of public screening survey. Diabetes International. 1999; 9: 59-60.
5. Omotoso ABO, Opadijo DG, Araoye MA. Diabetes mellitus and hypertension in Nigeria: a review of 572 diabetic patients. Nigeria Journal of Medicine. 1999; 8: 108-111.
6. Okesina AB, Omotoso ABO, Gadsama AA, Ogunriola EO. Frequency of hypertension in diabetic patients. International Diabetic Digest. 1996; 7: 39-40.
7. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities. The role of insulin resistance and the symathoadrenal system. NEJM. 1996; 334: 373-381.
8. Ginnr V, Coca A, Sierra A. Increased insulin resistance in salt-sensitive hypertension. J Hum Hypertens. 2001; 15: 481-485.
9. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol. 1999; 84(1A): 28-32.
10. Hotamisligil GS. The role of TNF alpha and TNF receptors in obesity and insulin resistance (Review). J Int Med. 1999; 245: 621-625.
11. Aitman TJ, Glazier AM, Wallace CA, Copper LD, Norsworthy PJ, Wahid FN et al. Identification of Cd36 (fat) as insulin resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genetics. 1999; 21: 76-83.
12. Verses BL. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences in the development of atherogenesis. Diabetes Metab. 1999; 25: 32-40.
13. Betteridge DJ. Diabetic dyslipidaemia. Eur J Clin Invest. 1999; 29: 12-16.
14. Sevanian A, Asatryan I, Ziouzenkora O. Low density lipoprotein modification: basic concepts and relationship to atherosclerosis. Blood Purification. 1999; 17: 66-78.
15. Witztum JL. The oxidative hypothesis of atherosclerosis. Lancet. 1994; 344: 793-795.
16. Adedeji OO, Onitiri AC. Plasma lipids in Nigeria hypertensives. Afr J Med Med Sci. 1990; 19: 281-284.
17. Isezuo AS, Badung SLH. Plasma lipids among Northwestern Nigerian hypertensives. Sahel Medical Journal. 2001; 4: 181-186.
18. Aduba O, Onowamaeze I, Oli J, Udeozo K. Serum cholestrerol and high density lipoprotein cholesterol in Nigerian diabetics. E Afr Med J. 1984; 61: 35-39.
19. Anaja HP, Isah HS, Abdu-Aguye I, Obura NA, Lipid profiles in Diabetic Nigerians: A Zaria update. International Diabetic Digest. 1995; 6: 90-93.
20. Wokoma FS. Hypertension in non-insulin dependent diabetic Nigerians: a comparative analysis of normotensive and hypertensive subgroups. Diabetes International. 1999; 9: 57-58.
21. Agboola-Abu CF, Onabolu A. Plasma lipid levels in patients attending Igbinedion Hospital and Medical Research Centre, Okada, Edo State, Nigeria. Nigeria Medical Journal. 2000; 38: 1-5.
22. Hypertension in Diabetes Study Group (HDS) 2: Increased risk of cardiovascular complications in hypertensive type 2 diabetes. J Hypertens. 1993; 11: 319-325.
23. Samler J, Vaccaro O, Neaton JD, Wenworh D. Diabetes, Other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16: 434-444.
24. World Health Organization (WHO). Report of a WHO Study Group. Diabetes mellitus. Tech Rep Ser. Geneva, 1995, 727.
25. World Health Organization (WHO)/Inter-national Society of Hypertension. Guidelines for the management of hypertension. Journal of Hypertension. 1999; 17: 151-183.
26. World Health Organization (WHO). Consultation on obesity. Classification according to BMI. Geneva, June 3-5, 1997.
27. Trinder P. Determination of blood glucose using 4-aminophenazone as oxygen carrier acceptor. J Clin Path. 1969; 22: 246.
28. Levine JB, Zak B. Ferric chloride method of determination of total cholesterol. Clin Chem Acta. 1964; 10: 381-384.
29. Busterin M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lip Res. 1970; 11: 583-595.
30. McGowan MW, Artiss JD, Strandergh DR, Zak BA. Peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983; 29: 583-542.
31. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in Plasma without use of preparative ultracentrifugation. Clin Chem. 1972; 18: 499-502.
32. European Atherosclerosis Society. Interna-tional Task Force for prevention of coronary heart disease, scientific back-ground and new clinical guidelines. Nutr Metab Cardiovascular Dis. 1992; 2: 113-156.
33. Jarikre AE, Ofogba CJ, Emuveyan EE. Reference values for the nutritional indices in urbanized adult Nigerians living in the Lagos area. Journal of Clinical Practice. 1998; 1: 22-25.
34. Sharma MD, Pavlick VN. Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001; 3: 41-45.
35. Knuiman JT, Hermus RJJJ, Wautrast JGAJ. Serum total and high-density lipoprotein cholesterol concentration in rural and urban boys from 16 countries. Aterosclerosis. 1980; 36: 529-537.
36. Levy LF. Atherosclerosis in Rhodesia. Afr J Med Med Sci. 1971; 2: 229-238.
37. Riccardi G, Rivellese AA. Effects of dietary fibre and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetic Care. 1991; 4: 1115-1125.
38. Adedeji OO. Diet alcohol consumption, smoking and exercise as determinants of blood lipids levels of Nigeria. WAJM. 200; 19: 283-285.
39. Olubodun JOB, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with or without heart failure. Int J Cardiol. 1990; 27: 229-234.
40. Shamiss AA, Caroll J, Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens. 1992; 5: 26-28.
41. Heger JW, Roth RF, Nieman JT, Criley JM. Ischaemic heart disease. In: Scatterfield TS (editor). Cardiology. Baltimore, MD. Williams and Wilkins, 1994: 130-136.
42. Opadijo GO, Omotoso ABO. Myocardial infarction as seen in University of Ilorin Teaching Hospital, Nigeria. Nigerian Medical Practitioner. 1998; 36: 49-51.
43. Oke DA, Talabi HAJ. Myocardial infarction as seen in Lagos University Teaching Hospital Lagos, Nigeria. Nigeria Journal of Medicine. 1997; 6: 43-45.